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ABSTRACT  
 
Background  
Malaria, an important parasitic disease, carries a huge burden locally and globally specifically 
imported malaria in non endemic industrialized regions like Gauteng. We evaluated the 
profile of patients treated for P. falciparum malaria at the Helen Joseph Hospital (HJH). 
 
Methods  
A retrospective review of 171 patient’s files was undertaken at HJH between January 2009 
and December 2010.  
 
Results 
Imported malaria contributed to an over-whelming 96% of the population, with males 
accounting for 85%. Pyrexia and thrombocytopenia were the most common features. Quinine 
and doxycycline combination was most frequent used treatment. The number of patients with 
complicated and uncomplicated malaria was almost equal. Mortality rate was 5.8% (10/171). 
Mortality in the HIV positive and negative groups was not found to be different. Females had 
a higher risk of severe malaria and its complications (p < 0.005). Admission to ICU predicted 
an even higher mortality rate. There were four predictors of mortality in ICU patients; severe 
hypotension, respiratory distress and/or ARDS and lastly the need for mechanical ventilation.  
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Conclusion  
Considerable progress has been made in malaria prevention and management however there 
are still significant prevention gaps that exist. The immense burden of imported malaria and 
male patient predominance was illustrated in this study. The demand for employment may 
have been the driving force here. The mortality rate was above national target of 0.5%. This 
places undue stress on the health system despite malaria being a preventable disease.   
VI 
 
ACKNOWLEDGEMENTS  
I would like to thank the following institutions and people: 
Associate Professor Colin Menezes, my supervisor, you have been a pillar of strength and a 
mentor for many years. It has been a privilege to work with you. Thank you for the excellent 
supervision and encouragement.  
Associate Professor Lucille Blumberg, National Institute for Communicable Diseases, for her 
expert opinion and advice. 
Mr Joe Venter, at National Health Laboratory Service at Helen Joseph Hospital, for his 
assistance with retrieving the laboratory results. 
Associate Professor Mohammed Tikly, for your constant advice and support.  
The staff at the Records department at Helen Joseph Hospital for assistance with retrieving 
the hospital files. 
I am also indebted to my family for the many years of support in my life and specifically in 
my career. My mum, Ronila Reddy and mum-in-law Saro Pillay, you have given me the 
opportunity to follow my dreams. I will forever be grateful to you.  
My loving and caring husband, Yugen Pillay, for always supporting my dreams and 
ambitions. Your unconditional support and confidence in me has allowed me to pursuit my 
deepest passions.  
Finally and in particular, I would like to express my gratitude to the patients at Helen Joseph 
Hospital, without whom, this undertaking would not be conceivable.  
  
VII 
 
TABLE OF CONTENTS  
DECLARATION ......................................................................................................................................... II 
DEDICATION ........................................................................................................................................... III 
ABSTRACT ............................................................................................................................................... IV 
ACKNOWLEDGEMENTS .......................................................................................................................... VI 
TABLE OF CONTENTS ............................................................................................................................. VII 
TABLES ..................................................................................................................................................... X 
FIGURES .................................................................................................................................................. XI 
ABBREVIATIONS .................................................................................................................................... XII 
CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW ......................................................................... 1 
1.1 INTRODUCTION ................................................................................................................... 1 
1.2 EPIDEMIOLOGY ................................................................................................................... 1 
1.2.1 Global .......................................................................................................................... 1 
1.2.2 South Africa ................................................................................................................. 1 
1.3 IMPORTED MALARIA ........................................................................................................... 2 
1.4 ODYSSEAN MALARIA ........................................................................................................... 3 
1.5 PREVENTION AND CONTROL............................................................................................... 4 
1.6 TRANSMISSION ................................................................................................................... 5 
1.7 DIAGNOSIS .......................................................................................................................... 5 
1.8 SUSCEPTIBLE PATIENT GROUPS .......................................................................................... 6 
1.8.1 Malaria in pregnancy .................................................................................................. 7 
1.8.2 Malaria and HIV co-infection ...................................................................................... 7 
1.9 CLINICAL DIAGNOSIS ........................................................................................................... 8 
1.9.1 Non specific symptoms and delays in diagnosis ......................................................... 8 
1.9.2 Clinical signs ................................................................................................................ 9 
1.9.3 WHO severe malaria criteria ....................................................................................... 9 
1.9.4 Cerebral malaria ........................................................................................................ 10 
1.9.5 Circulatory collapse ................................................................................................... 11 
1.9.6. Respiratory distress and Acute Respiratory Distress Syndrome ..................................... 11 
1.10 LABORATORY FEATURES ................................................................................................... 12 
1.10.1 Anemia and Thrombocytopenia ............................................................................... 12 
1.10.2 Renal failure .............................................................................................................. 13 
1.10.3 Acidosis ..................................................................................................................... 13 
1.10.4 Hypoglycemia and hyperbilirubinemia ..................................................................... 13 
VIII 
 
1.10.5 Parasitemia ............................................................................................................... 14 
1.11 CRITICAL CARE MANAGEMENT OF SEVERE MALARIA ...................................................... 14 
1.12 MORTALITY ....................................................................................................................... 16 
1.13 TREATMENT OPTIONS ....................................................................................................... 17 
1.14 RATIONALE, AIMS AND OBJECTIVES FOR RESEARCH ........................................................ 19 
1.14.1 Rationale for Research .............................................................................................. 19 
1.14.2 Aims ........................................................................................................................... 19 
1.14.3 Specific Objectives .................................................................................................... 19 
CHAPTER 2 MATERIALS AND METHODS ............................................................................................... 21 
2.1. Site of Study ...................................................................................................................... 21 
2.2. Study Design and Sampling ............................................................................................... 21 
2.3. Data collection and diagnostic criteria for severe malaria ............................................... 22 
2.4. Ethics approval and other considerations ........................................................................ 23 
2.5. Statistical Analysis ............................................................................................................. 24 
CHAPTER 3 RESULTS .............................................................................................................................. 25 
3.1. Demographic Information ................................................................................................. 25 
3.1.1. Age and Gender Distribution .................................................................................... 25 
3.1.2. Travel history and Place of Citizenship ..................................................................... 26 
3.1.2.1. Travel History ........................................................................................................ 26 
3.1.2.2. Place of citizenship ................................................................................................ 27 
3.2. Seasonal Variation ............................................................................................................ 27 
3.3. Clinical Spectrum of Disease ............................................................................................. 28 
3.4. Laboratory Features .......................................................................................................... 29 
3.4.1. Hematological and biochemical tests ....................................................................... 29 
3.4.2. Malaria Tests ............................................................................................................. 30 
3.5. Management ..................................................................................................................... 31 
3.5.1. Inpatient versus outpatient management ................................................................ 31 
3.5.2. Treatment options .................................................................................................... 32 
3.5.3. Outcome ................................................................................................................... 32 
3.5.3.1. Mechanical Ventilation ......................................................................................... 32 
3.5.3.2. Haemodialysis ....................................................................................................... 32 
3.5.3.3. Discharge versus death ......................................................................................... 32 
3.5.3.4. Malaria deaths ...................................................................................................... 33 
3.6. Gender differences and outcome ..................................................................................... 34 
IX 
 
3.7. Malaria and pregnancy ..................................................................................................... 35 
3.8. Malaria and HIV................................................................................................................. 35 
3.9. Complicated versus uncomplicated malaria ..................................................................... 36 
3.10. ICU Admissions .............................................................................................................. 36 
3.10.1. Clinical findings ......................................................................................................... 36 
3.10.2. Predictors of mortality in ICU ................................................................................... 37 
CHAPTER 4 DISCUSSION ........................................................................................................................ 39 
LIMITATIONS ......................................................................................................................................... 45 
CONCLUSION ......................................................................................................................................... 46 
REFERENCES .......................................................................................................................................... 49 
APPENDIX 1 ........................................................................................................................................... 52 
APPENDIX 2 ........................................................................................................................................... 53 
 
  
X 
 
TABLES 
Table 1: Clinical features of patients admitted with malaria at HJH ............................... 29 
Table 2: Laboratory findings of patients admitted with malaria at HJH 2009/2010 ...... 31 
Table 3: Differences in gender and outcome ....................................................................... 34 
Table 4: Comparison of patients discharged and those that demised in ICU .................. 37 
 
  
XI 
 
FIGURES 
Figure 1 Age distribution of the study group ...................................................................... 25 
Figure 2 Gender distribution of the study population ........................................................ 26 
Figure 3 Percentage distribution of Travel Place ............................................................... 27 
Figure 4 Seasonal Variation of patients with malaria ........................................................ 28 
 
 
  
XII 
 
ABBREVIATIONS  
 
AKI Acute Kidney Injury 
ARDS Acute Respiratory Distress Syndrome 
ACT Artemisinin Combination Therapy 
AIDS Acquired Immune Deficiency Syndrome  
DDT Dichlorodiphenyltrichloroethane 
DOH Department Of Health 
Hb Hemoglobin 
HIV Human Immunodeficiency Virus 
HJH Helen Joseph Hospital 
ICU Intensive Care Unit 
RAT Rapid Antigen Test 
RRT Renal Replacement Therapy  
SA South Africa 
SP Sulphadoxine-Pyrimethamine  
WHO World Health Organization 
1 
 
CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW 
1.1 INTRODUCTION 
Malaria is the most important and prevalent parasitic disease in humans, posing an enormous 
global public health burden (Suh et al, 2004). It is a disease that has entrenched 
disproportionately in poverty stricken areas of the world. The social and economic burden 
created by this devastating disease in these developing countries is immense. Over 40% of 
the world’s population is said to live in malaria endemic areas (Suh et al, 2004). Almost a 
million people around the globe die each and every year from this dreadful infection (Marks 
et al, 2014).  
 
1.2  EPIDEMIOLOGY 
1.2.1 Global 
According to the World Malaria Report in 2010, the global prevalence of the disease was 
estimated at 225 million cases in 2009. Further, there were 781 000 deaths reported in that 
year (World Health Organization [WHO] 2010). Sub-Saharan Africa hosts the vast majority 
(80%) of these malaria cases, predominantly saturating remote rural areas with poor access to 
health services (Ngomane et al, 2012). Despite a constantly evolving field of knowledge, the 
morbidity and mortality caused by this devastating disease globally is tremendous (Suh et al, 
2004). This has direct impact and negative consequences on the economic growth of the area. 
Most of the falciparum malaria across the USA and Europe is acquired from Sub-Saharan 
Africa (Marks et al, 2014).  
 
1.2.2 South Africa  
In South Africa transmission of malaria is low and seasonal (Weber et al, 2010). Infection 
rates have been reported to be reduced and is now limited to a small area in the North- 
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Eastern part of the country (Kwa-Zulu Natal, Mpumalanga and Limpopo provinces) 
(National Department of Health [DOH], 2009). Almost all South Africans are non-immune to 
malaria thereby escalating their risk of severe malaria (DOH, 2010). Due to malaria being a 
nationally notifiable disease, reduced infection rates has been confirmed with a decrease in 
the number of malaria notifications reported in the country. In 2000 there were just over 60 
000 notifications, however in 2010 there was a substantial decrease to approximately 8000 
(Moonasar et al, 2011). Mpumalanga province however, is one of the country’s provinces 
that still experiences relatively high volumes of unstable malaria transmission, by 
contributing to 44% of the country’s notified malaria cases (National DOH 2007). While 
malaria is now limited to the smaller areas in the country (Weber et al, 2010), migrants and 
mobile populations still represent a significantly high percentage of the total number of cases 
(Opie et al, 2014). 
 
1.3 IMPORTED MALARIA  
The most common cause of imported infection in non endemic areas is actually malaria, 
mostly falciparum (Marks et al, 2014). This is a direct consequence of the escalated travel 
between endemic and non endemic areas (Marks et al, 2014). Gauteng is an area non-
endemic to malaria due to its altitude and also its climate (Frean et al, 2014). Being an 
economic hub of the country, the province has seen an alarmingly high incidence of the 
disease. Around 20% of the country’s malaria burden is actually generated here in Gauteng 
through imported malaria (Frean et al, 2014). This may be related to travelers entering the 
city of gold from endemic areas outside South Africa (Weber et al, 2010. Perovic et al, 2000. 
Frean et al, 2014). Many foreigners working in the Sub-Saharan areas are also flown into 
Gauteng during periods of illness. Imported malaria is exclusively a disease of the young to 
middle-aged adult, contrary to endemic areas where it mainly affects children (Marks et al, 
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2014). The escalation of immigrant workers travelling through endemic regions into Gauteng 
in the face of employment has been a critical point (Weber et al, 2010). According to the 
report compiled by the United Nations Refugee Agency, South Africa was the main overall 
destination country of thousands of new asylum seekers between 2006 and 2011. These 
numbers are probably underestimated though, as not many migrants are registered asylum 
seekers (Opie et al, 2014). Presentation to a health institute frequently follows recent travel of 
foreign migrants. This places strain and a huge burden on the health system of the country. 
Very few study reports however actually focus on the impact of imported malaria specifically 
in non-endemic industrialized areas (Weber et al, 2010; Bruneel et al, 2003).  
 
1.4 ODYSSEAN MALARIA  
Malaria acquisition in non-endemic areas can occur (Frean et al, 2014). The entity of airport / 
suitcase malaria was first recognized in Europe in the 1970’s (Frean et al, 2014). Odyssean 
malaria is a rare form of malaria transmitted by mosquitoes that have been translocated 
(Frean et al, 2014). Travel history is typically non- existent in these patients and the 
possibility of transfusion related malaria is also excluded. The probable source of 
translocated mosquitoes remains with all vehicles of transport including air, road and rail 
traffic from within and outside South Africa (Frean et al, 2014). Road transport is probably 
more important than air transport as a source of translocated mosquitoes from endemic 
regions (Frean et al, 2014). In Gauteng, possible sources of translocated malaria- infective 
mosquitoes are from neighboring countries, mainly Mozambique as well as Zimbabwe (Frean 
et al, 2014). Translocation within endemic areas of the country is also possible. In view of the 
negative travel history in this group of patients, malaria is not always initially considered. 
Hence the diagnosis is almost always delayed thereby promoting cases of complicated 
malaria and increased mortality (Frean et al, 2014). Although falciparum malaria is a 
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significant cause of morbidity and mortality across the world, it is also a preventable one too 
(Suh et al, 2004).      
 
1.5  PREVENTION AND CONTROL 
Vector control has been the most effective method of reducing malaria transmission. 
Dichlorodiphenyltrichloroethane (DDT) is one of the most effective pesticides used to control 
malaria. In the 1940’s house-spraying with DDT was done as large scale prevention 
programme in South Africa. This prompted a decrease in the level of malaria transmission in 
large parts of the country. Major malaria vectors Anopheles funestus and Anopheles gambiae, 
were also eliminated (Ngomane et al, 2012). Use of insecticide has raised many concerns as 
the chemical fumes may be hazardous (Ngomame et al, 2012).  
Malaria transmission occurs mainly between dusk and dawn as the Anopheles mosquitoes 
feed at night (Moonasar et al, 2013). Therefore reduced contact with the mosquitoes 
especially during these hours is important. Insect repellants containing diethyl-meta- 
toluamide (DEET) can be applied to exposed skin (Moonasar et al, 2013). Bed nets provide a 
physical barrier to mosquitoes. Further, the effectiveness is greatly improved if treated with 
insecticides like permethrin (Suh et al, 2004). This generates a chemical halo that extends 
beyond the net as a repellent. 
Malaria is preventable in travelers (Suh et al, 2004). Data consistently illustrates that 
travelers do not adhere to malaria prophylaxis appropriately (Marks et al, 2014). One may 
either assume that their risk is low, particularly those that grew up in an endemic area or there 
may be concern about anti-malarial side effects. Prophylactic anti-malarial drugs include 
mefloquine, doxycycline and malarone (atovaquone-proguanil) (Moonasar et al, 2013). No 
prophylaxis is a 100% effective. Even if there is failure of the prophylactic drug it may confer 
some degree of protection against complicated malaria (Seringe et al, 2011). Travelers must 
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be educated about the importance of these preventive measures and immediate presentation to 
a health institute should they experience a fever (Suh et al, 2004).   
 
1.6 TRANSMISSION  
Tropical and subtropical areas promote breeding and enhance transmission due to the warm 
humid climates with heavy rainfall (Marks et al, 2014).  
There are approximately 3500 species of mosquitoes grouped into 41 genera. A bite from an 
infected female of the genus Anopheles transmits human malaria. Infection can also be 
transmitted through blood transfusion and congenital transmission (Trampuz et al, 2003).  
Malaria in humans is caused by one of five species including Plasmodium falciparum; P. 
ovale; P. malariae; P. vivax and P.knowlesi. The likelihood of the non falciparum malaria 
causing severe malaria is of low probability (Cohen et al, 2005). Infection with P. falciparum 
has been shown to cause the most clinically severe and complicated form of malaria. Over 
90% of all malaria in Africa is from P. falciparum (Suh et al, 2004. Perovic et al, 2000).  
 
1.7 DIAGNOSIS  
Early diagnosis and prompt access to treatment remains the cornerstone. Microscopy is the 
gold standard for diagnosis and has the advantage that it can be used for speciation, 
quantification of parasites and hence response to malaria treatment (Singh et al, 2010. Marks 
et al, 2015). It may also identify other causes of fever if not malaria. The peripheral smear 
stained with Giemsa demonstrates the parasite on a thick film. Thin films assist with 
determination of parasitemia densities and species identification (Trampuz et al, 2003). The 
presence of schizonts on blood smear can be a marker of severity (Marks et al, 2014). 
Microscopy may however be a serious obstacle to therapeutic delays since it is labor 
intensive and requires skilled staff. Additionally, laboratory errors may occur even in the 
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hands of the skilled as it can take many years of experience and skill to accurately interpret 
malaria slides (Singh et al, 2010).  A smear should be repeated if there is a high index of 
suspicion for malaria with an initial negative smear. Parasitemia quantification is a predictor 
of severe malaria and prognosis. However due to it being technician dependant there may be 
much variability especially in a semi-immune patient. 
Malaria remains a diagnostic challenge more especially in resource limited settings (Singh et 
al, 2010). The introduction of the Rapid Diagnostic Tests (RDT’s) is fast and simple to use in 
malaria diagnosis allowing for rapid institution of anti-malarial treatment (Singh et al, 2010). 
It is used for the qualitative detection of P falciparum on blood. RDT’s detects parasite 
associated proteins and enzymes like the histidine rich protein II (HRPII) antigen (Perovic et 
al, 2000. Trampuz et al, 2003. Marks et al, 2014). Due to the high sensitivity of RDT’s for 
falciparum malaria, there is a reduced risk of missing a patient infected with malaria (Singh 
et al, 2010). Important shortcomings however is that these tests are expensive, vulnerable to 
high temperatures and humidity, suboptimal with low parasitemia levels and can neither 
quantitate parasitemia nor differentiate between species (Singh et al, 2010). The RDT 
although enhances the speed of diagnosis, smear microscopy is still mandatory (Trampuz et 
al, 2003). It should be considered as an adjunct the diagnostic arm. The role for PCR as a 
diagnostic tool for malaria remains more for research purposes (Marks et al, 2014).   
     
1.8 SUSCEPTIBLE PATIENT GROUPS  
South African residents including those from malaria areas are generally non immune and 
therefore are at high risk of complicated malaria (DOH 2010).  Any age group can be 
susceptible to malaria infection however mortality rates escalates in children, elderly, 
splenectomised individuals, pregnant or postpartum females and HIV groups with malaria 
complications (DOH, 2010).  
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1.8.1 Malaria in pregnancy  
An increased risk of parasitic infections especially falciparum malaria has been well 
described in pregnant females (McLean et al, 2015). It appears that there may be an increased 
risk of P. vivax as well in pregnancy. However data is somewhat conflicting (McLean et al, 
2015). Apart from pregnant women having a higher susceptibility to falciparum malaria than 
non pregnant, the risk of infection is remarkably higher in primigravid females (McLean et 
al, 2015). The underlying pathological process involves changes in hormonal and 
immunological systems in pregnancy. Malaria in pregnancy can have a negative impact on 
both mother and fetus (McLean et al, 2015). In the mother it has been associated with an 
increased risk of hypoglycemia, anemia, severe complicated malaria, pulmonary edema and 
death. Malaria in the post partum period is also documented as is the risk of post-partum 
hemorrhage. The effect on the fetus may include miscarriage, intrauterine growth retardation, 
premature birth, congenital infection and perinatal death (WHO 2000).  
 
1.8.2 Malaria and HIV co-infection 
Due to geographical distribution, malaria endemic areas are found to have a distinctly high 
prevalence of HIV infection as well (Pereira et al, 2015). This overlap of infections augments 
the possibility that travelers coming from endemic areas may well present with co-infection 
(Pereira et al, 2015). The consequence of this co-infection may be detrimental as the severity 
of malaria is escalated with HIV co-infection. These patients seem to have a higher parasite 
burden and the risk of severe malaria and its complications is escalated (Pereira et al, 2015). 
Parasite density is said to directly correlate with the degree of immune-suppression. HIV co-
infection particularly in non immune patients has higher risk of severe malaria, its associated 
morbidity and mortality (Cohen et al, 2005. DOH, 2010). The risk of severe malaria is 
associated with a low CD4 count (Cohen et al, 2005). Additionally, malaria can accelerate 
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the progression of HIV disease itself (Pereira et al, 2015). An immunological interaction 
occurs between both diseases, favoring the spread and viral replication of HIV (Pereira et al, 
2015). In patients with co-infection opportunistic infections may be easily confused with 
features of malaria infection (Mehta et al, 2007). Patients can be incorrectly diagnosed as 
tuberculosis meningitis or cryptococcal meningitis when in actual fact the diagnosis is 
cerebral malaria and vice versa (Mehta et al, 2007). Fever may be the cardinal feature to all 
these infections hence lending itself to a major diagnostic dilemma (Pereira et al, 2015). The 
interaction of malaria and HIV is well established and acknowledged in endemic areas, 
however it may be lacking in non endemic areas (Pereira et al, 2015). The clinician should 
therefore have a high index of suspicion for malaria in a febrile patient with HIV, more 
especially in a malaria endemic region (Mehta et al, 2007). Screening for both malaria and 
HIV infections are advocated in any patient with travel history (Pereira et al, 2015).   
 
1.9 CLINICAL DIAGNOSIS   
 
1.9.1 Non specific symptoms and delays in diagnosis 
The times between an infective mosquito bite and the start of illness is usually 7 to 21 days 
(average of 10 days) in P. falciparum. The vast majority of patients classically experience 
fever, chills, headache and diaphoresis (Trampuz et al, 2003. DOH, 2010). Other symptoms 
include malaise, myalgia abdominal pain, nausea and vomiting. These are however non-
specific symptoms and frequently lead to mis-diagnosis of malaria. The clinical diagnosis of 
malaria can therefore be challenging and requires a high index of suspicion as the symptoms 
can mimic many other diseases more especially influenza (DOH, 2010). Health care workers 
in non malaria areas may have a low index of suspicion for malaria or to even recognize the 
clinical features thereof. This directly contributes to a delay in diagnosis and directed 
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management (Weber et al, 2010). Failure to diagnose falciparum malaria promptly and hence 
subsequent delay in targeted management results in progression to complicated malaria and 
morbidity and mortality heightens (Perovic et al, 2000. Trampuz et al, 2003). Malaria is one 
of the most common causes of febrile illness in a returning traveler (Marks et al, 2015). Any 
patient that presents with non specific symptoms like fever and has a travel history to a 
malaria endemic area must be screened for malaria. Further, the differential diagnosis must 
include malaria when there is concern for pyrexia of unknown origin. Poor patient insight and 
awareness also has direct impact on presentation to a health care facility. It has been singled 
out as a definite problem requiring attention (Perovic et al, 2000). 
 
1.9.2 Clinical signs  
Examination of a patient may be completely unremarkable or may include tachycardia, fever, 
jaundice, pallor, hypotension (Trampuz et al, 2003). Signs of specific organ involvement may 
also be present. Severe falciparum malaria can manifest as a complex multi-system disease 
involving respiratory, renal and hematological or the central nervous systems. Metabolic 
complications including hypoglycemia or metabolic acidosis may also occur (Trampuz et al, 
2003).  
 
1.9.3 WHO severe malaria criteria 
In 1990 the WHO established the criteria for severe falciparum malaria (WHO, 1990). In 
2000 these criteria were revised, providing additional information and highlighting the 
specific risk factors of severe complicated malaria. These criteria include clinical 
manifestations and laboratory values. Major complications of severe falciparum malaria 
include circulatory collapse; bleeding; pulmonary edema; cerebral malaria; hypoglycemia; 
anemia; acute renal failure and/or metabolic acidosis (WHO, 2000). These complications 
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may coexist or evolve within hours of presentation (Trampuz et al, 2003). The Department of 
Health guidelines of South Africa closely follows and is based on the WHO guidelines 
(DOH, 2013). Severe malaria is a medical emergency requiring rapid and appropriate therapy 
and neglect thereof results in rapid progression of disease and its complications (DOH, 2013).   
Currently the WHO criteria are used in most countries to diagnose patients with malaria. 
However these criteria have been based on studies done in endemic areas (Bruneel et al, 
2003). Further the prognostic value of these criteria in adult patients with severe imported 
malaria is poor. There are few studies done on the presentation and complications of patients 
seen with imported malaria in non-endemic areas (Bruneel et al, 2003). In addition, 
definitions and criteria exist to assist clinicians on a clinical level and also for research basis. 
However in clinical practice it is important to emphasize that one should not defer treatment 
due to lack of fulfillment of these criteria (WHO, 2000). Every patient can present 
differently. Moreover these criteria may actually be present in many other diseases as well. 
Due to the high associated mortality and morbidity, if there is a suspicion for the disease, the 
benefit should be given to treat while awaiting further laboratory test results (WHO, 2010).  
 
1.9.4 Cerebral malaria  
Cerebral malaria is one of the most feared and most fatal complications of severe falciparum 
malaria. Patients may present with neck stiffness, abnormal posturing, depressed level of 
consciousness, convulsions or coma. Eye abnormalities like retinal hemorrhages or disorders 
of conjugate gaze may also occur (WHO 2000). Clinicians should be aware that convulsions 
may also indicate hypoglycemia. Other causes of a decreased level of consciousness should 
be excluded like hypoglycemia, meningitis or encephalitis (Trampuz et al, 2003). The strict 
definition of cerebral malaria requires a Glasgow Coma Scale score of below 6 together with 
the presence of a parasitemia. However, for practical purposes any alteration in level of 
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consciousness should be considered and treated as cerebral malaria (Trampuz et al, 2003). 
The pathophysiology of cerebral malaria is poorly understood and the mortality can escalate 
to even 50% with treatment (Trampuz et al, 2003). A well recognized complication within 
this category also includes cerebral edema (Marks et al, 2014). The use of dexamethasone 
and mannitol has been associated with prolonged coma states (Marks et al, 2014).  
 
1.9.5 Circulatory collapse  
Circulatory collapse defined as a systolic blood pressure ≤ 80mmHg may be associated with 
dehydration and hypovolemia. Bacterial sepsis, pulmonary edema, hemorrhage and acidosis 
are also important and possible contributors (WHO, 2000).  
 
1.9.6. Respiratory distress and Acute Respiratory Distress Syndrome (ARDS)  
Respiratory distress in these patients may be related to firstly a primary lung involvement that 
being acute lung injury, ARDS or even pneumonia. Secondly, it may be an expression of the 
underlying metabolic acidosis, anemia or fever (Marks et al, 2014). Acute lung injury can 
occur early in the course of disease. It can occur rapidly and sometimes despite an initial 
response to therapy and a decrease in parasitemia (Trampuz et al, 2003. Suh et al, 2004). 
Pulmonary edema is non cardiogenic and can manifest as tachypnoea and dyspnoea, followed 
with hypoxemia and respiratory failure (Trampuz et al, 2003). Pulmonary edema may 
progress to Acute Respiratory Distress Syndrome (ARDS) which can be defined as an acute 
lung injury and an arterial oxygen tension/fractional inspired oxygen ratio of ≤ 200mmHg 
(Trampuz et al, 2003). The underlying pathology lies with there being an immune mediated 
complication (Suh et al, 2004), causing increased permeability at the level of the pulmonary 
capillaries. Interestingly, evidence is now pointing to the free parasite antigens that can 
persist after malaria therapy, resulting in a potential consistent stimulus for inflammatory 
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response (Marks et al, 2014).  Hypoalbuminemia and volume overload may aggravate 
capillary leakage (Trampuz et al, 2003). The aim therefore is to avoid aggressive fluid 
resuscitation. The maintenance of intravascular volume at a level providing adequate 
systemic perfusion is the cornerstone to fluid resuscitation (Trampuz et al, 2003). Both 
respiratory distress and ARDS are markers of poor prognostic features in imported and 
endemic cases (Marks et al, 2014). The mortality associated with pulmonary edema can be as 
high as 80% (WHO, 2000).  
 
1.10 LABORATORY FEATURES  
 
1.10.1 Anemia and Thrombocytopenia  
There have been many hematological changes noted in malaria. Severe anemia forms one of 
the WHO criteria of severity and has been associated with increased morbidity and mortality. 
Various degrees of anemia can be found ranging from slightly below normal; moderate 
(Hemoglobin [Hb] 5.1 to 10g/dl) and then severe life-threatening (Hb < 5g/dl). The 
mechanisms of the anemia in malaria may be multifactorial. Hemolysis and inappropriate 
marrow response largely contributes to anemia (DOH, 2010). Drug related causes may also 
play a role like artemesinin-induced haemolysis of parasitized red blood cells.   
Thrombocytopenia is not a criterion of severe malaria. It is however one of the most common 
laboratory findings. It is likely due to splenic sequestration and consumption (Marks et al, 
2014). With regard to the entity of Odyssean malaria explained above, a patient with 
unexplained fever and thrombocytopenia must be tested for malaria even in the absence of a 
travel history (Frean et al, 2014). Usually thrombocytopenia on its own is not associated with 
bleeding (DOH, 2010). Additional factors like disseminated intravascular coagulopathy 
(DIC) causes an increased risk of significant bleeding.  
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1.10.2  Renal failure  
Falciparum malaria is the most common species causing an acute kidney injury (AKI) 
(Marks et al, 2014). Many patients presenting with malaria have a history of vomiting and 
decreased appetite hence contributing to a state of dehydration. Often this pre-renal 
dysfunction is restored to normal with rehydration. Other mechanisms of renal injury 
documented in malaria include an immune mediated glomerulonephritis and an acute tubular 
necrosis (Marks et al, 2014). The risk of AKI is estimated to be as high as 25-50% in 
imported cases of malaria (Marks et al, 2014). While quinine doses require dose adjustment 
in AKI, artemisinin derivatives do not need adjustment (Marks et al, 2014). The outcome of 
renal dysfunction has been showed to be positive and full recovery ultimately (Marks et al, 
2014).   
 
1.10.3 Acidosis  
Metabolic acidosis may be multi-factorial in severe malaria. Hypovolaemia, anemia and 
obstruction of microvascular circulation by sequestered parasites all contribute to reduced 
tissue perfusion. The clinical picture of respiratory distress is exacerbated by severe 
metabolic acidosis. The presence of metabolic acidosis is a severe malaria feature and heralds 
an associated increased mortality risk (WHO, 2000). Lactic acidosis can occur due to tissue 
anoxia and anaerobic glycolysis (WHO, 2000). The degree of hyperlactatemia is said to 
directly correlate with the degree of parasite microvascular sequestration rather than 
hypovolemia (Marks et al, 2014).  
 
1.10.4 Hypoglycemia and hyperbilirubinemia  
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Hypoglycemia is commonly seen in pregnant patients and those with severe falciparum 
malaria. The pathophysiology may be related to impaired gluconeogenesis or increased 
glucose consumption by both parasite and host (Marks et al, 2014). Drug related 
hypoglycemia is also well documented especially with quinine.  
The combination of thrombocytopenia and hyperbilirubinemia in a traveler has a positive 
predictive value of 95% (Trampuz et al, 2003). 
 
1.10.5 Parasitemia  
Quantitative parasitemia can be technician dependant and thereby lend itself to much 
variability. It can however indicate severity to an extent and its trend can also be used to 
monitor therapeutic response to anti-malarial therapy (Frean et al, 2014). Parasite density 
greater than 2% in non endemic areas is associated with severe malaria more often than not, 
however lower counts cannot exclude it (Marks et al, 2014). Peripheral smears may not 
accurately capture the actual parasite burden (DOH, 2010). Due to the sequestration of 
parasitized erythrocytes, the parasite density on peripheral smear may not be a true reflection 
of actual parasite burden (Marks et al, 2014).  Therefore for these reasons, hyperparasitemia 
may not be a consistent finding with severe malaria. Both a higher total body parasite burden 
and sequestered parasites contribute to disease severity (Marks et al, 2014).   
 
1.11 CRITICAL CARE MANAGEMENT OF SEVERE MALARIA 
Patients with malaria may have rapid deterioration and turn for the worse (Marks et al, 2014). 
Severe malaria is a medical emergency and should be managed in an Intensive Care Unit 
(Santos et al, 2012). The admission of a patient to ICU is usually associated with a greater 
mortality (Marks et al, 2014). The most frequent factors validating ICU support are acute 
kidney injury (AKI), ARDS and cerebral malaria whether on its own or in combination 
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(Marks et al, 2014). Despite institution of appropriate therapy, the patient’s clinical condition 
can rapidly deteriorate due to the systemic inflammatory response and multi-organ failure 
(Santos et al, 2012)). Continuous and close monitoring is essential to reduce the associated 
risk of mortality (Santos et al, 2012). Cardiac dysfunction although not well researched, has 
evidently been found to play a role in severe malaria as well (Marks et al, 2014). There have 
been studies documenting detectable levels of cardiac enzymes and pro-BNP in patients with 
severe malaria (Marks et al, 2014). It would appear that additional research is required in this 
territory to fill the gaps and understand its clinical relevance in these patients (Marks et al, 
2014).  
Fluid balance in malaria patients is of critical importance. The argument against rapid and 
liberal fluid expansion is that it may consequently follow with capillary leak and pulmonary 
and cerebral edema (Marks et al, 2014). Mortality rate has been shown to escalate in patients 
receiving fluid boluses as opposed to those on maintenance fluids only (Marks et al, 2014). 
Studies have pointed to a phenomenal increase in the risk of pulmonary edema in patients 
who were aggressively fluid resuscitated despite being euvolemic or even hypovolemic 
(Marks et al, 2014). Positive fluid balances meant worse outcomes. The bottom line is that 
one should exercise caution with fluid administration in these critically ill patients. Early 
inotropic support may be required for haemo-dynamic support rather than the risk of over-
hydration and that of acute lung injury (Trampuz et al, 2003). Further, prompt institution of 
haemodialysis may reduce the risk of acute lung injury and probably even death (Trampuz et 
al, 2003). Mechanical ventilation may be required in patients with depressed level of 
consciousness or acute lung injury (Trampuz et al, 2003). The mortality rate can actually be 
elevated even with high standards and experienced ICU (Bruneel et al, 2010).  
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1.12 MORTALITY   
Despite effective preventative and curative measures, sadly patients still die from malaria 
(Mehta et al, 2007). Advances in patient management have been ongoing however the 
mortality rate estimated for patients with severe malaria remains around 10% (Marks et al, 
2014). A lack of clinical experience and recognition of severe malaria contributes to the 
increased mortality (Mehta et al, 2007). Data from studies done in the UK emphasize that this 
outcome is probably worse in areas with poor experience in managing severe malaria (Marks 
et al, 2014). Almost all severe malaria cases and associated mortality is due to P falciparum 
infection (Trampuz et al, 2003. Suh et al, 2004. Perovic et al, 2000. Marks et al, 2014). 
Mortality rate is estimated at 1 million deaths every year (Marks et al, 2014)). Sub-Saharan 
Africa hosts 90% of these deaths, unfortunately children bearing the major brunt (Suh et al, 
2004). Most life threatening complications have been described in non-immune travelers 
returning from endemic areas (Trampuz et al, 2003). The mortality rate of severe imported 
malaria is estimated to be 10-15% (Bruneel et al, 2010). Risk factors for mortality should be 
identified promptly facilitating optimal treatment care. However there have been various 
studies that have identified different factors as contributing risks for severe malaria and death. 
The national target case fatality rate is 0.5%. A confidential study done identified many 
problems contributing to increased mortality rate at health care institutes in three provinces in 
South Africa (Mehta et al, 2007). The causes that were highlighted included delay in prompt 
access to health care, delayed admission of outpatients with severe malaria, inadequate 
inpatient care, inappropriate drug treatment and non- response or adverse drug effects to the 
anti-malarials (Mehta et al, 2007). Early institution of the appropriate therapy certainly 
reduces mortality and correlates with improved outcome. 
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1.13 TREATMENT OPTIONS  
There are different anti-malarial drugs with differing modes of action against different 
species of the malaria parasite as well as targeting different stages of development in the life 
cycle of the disease. The treatment of falciparum malaria is a medical emergency requiring 
prompt institution of anti-malarial therapy (Suh et al, 2004). The emergence of resistant 
strains poses a problem on the management of infected patients. The development of initially 
chloroquine resistance and subsequently sulphadoxine-pyrimethamine (SP) prompted 
changes in South African treatment policies (DOH, 2010).  
Combination therapy is advocated over monotherapy in an attempt to combat the issue of 
resistance (DOH, 2010). The improved treatment outcomes of artemisinin- based 
combination therapy (ACT) have most definitely been proved by its cost effectiveness (DOH, 
2010). 
Artemether-lumefantrine (Coartem) which is basically an artemisinin plus another anti-
malarial agent is recommended by the WHO as first line therapy for uncomplicated malaria. 
Alternatively if this cannot be used then quinine with either doxycycline or clindamycin can 
be used. If the patient cannot tolerate oral therapy then intravenous treatment is indicated 
(Suh et al, 2004).  
Severe malaria requires in-patient care in hospital. Intravenous quinine has been the mainstay 
of therapy (Marks et al, 2014). However in the recent years, artemisinin’s have become more 
popular. Intravenous artesunate is now advocated over quinine and should be used as the 
preferred agent for treatment of severe malaria (Marks et al, 2014). WHO has endorsed 
intravenous artesunate as the standard of care over quinine specifically in severe malaria 
patients (WHO 2006). Firstly, it has a superior safety profile and secondly, it has mortality 
benefits (Visser Kift et al, 2011). Severe malaria carrying the high mortality rate that it does 
(10 – 50%) requires prompt and effective therapy to prevent death (Visser Kift et al, 2011). 
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Artesunate has shown to have a rapid parasite clearance and broad stage specificity (Visser 
Kift et al, 2011). Two major trials, the SEAQUAMAT and the AQUAMAT studies 
illustrated significant decrease in mortality rates with artesunate (Marks et al, 2014). 
Additionally, artesunate can also be safely administered and with better tolerability. Its 
effectiveness in the treatment of patients with complicated malaria has favored its use. 
Artesunate was approved for use by the Medicines Control Council (MCC) in June 2009. It 
was then launched in South Africa in January 2010 and was only available for use under 
Section 21 of the Medicines and Related Substances Act (Visser Kift et al, 2011). Of 
importance and concern is that partial resistance against artemisinin has also been 
documented in certain areas like Cambodia and Thailand (Marks et al, 2014).  
If artesunate is unavailable, then intravenous quinine with either doxycycline or clindamycin 
is recommended. The cardiotoxic and hypoglycemic side effects of quinine however, 
demands strict monitoring thereof and administration through drug infusion pump (Trampuz 
et al, 2003).  
Although the ACT’s forms part of national policy in malaria-risk areas in the country, this 
therapy is not accessible in other areas (Weber et al, 2010). Hence this makes quinine the 
drug of choice. There should be no delay in using quinine while trying to access artesunate 
(Marks et al, 2014).  
There may be a rise in parasitemia counts in the first 12 to 24 hours after commencing anti- 
malarial treatment. However a rise in parasitemia beyond 48 hours of starting anti-malarials 
may indicate treatment failure (Trampuz et al, 2003).  
Severe malaria is a multisystem disorder and each organ complication requires specific 
management thereof. This makes the treatment approach of severe malaria a multi-faceted 
one. Apart from the anti-malarial drug therapy, fluid status, anemia and bleeding must be 
addressed. Seizures should be treated with anticonvulsants. Secondary bacterial infections are 
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not uncommon and may be masked by the malaria infection itself. These infections must be 
treated appropriately and promptly (Trampuz et al, 2003).  
Some patients may require mechanical ventilation, hemodynamic or haemodialysis support. 
Exchange transfusion has been a treatment option in some patients with severe parasite 
infestation and severe malaria, however its benefit is a controversial one and there are very 
few trials supporting its effectiveness (Trampuz et al, 2003. Bruneel et al, 2010). There 
should be a low threshold for early advice from an expert or Infectious disease unit (Marks et 
al, 2014).  
 
1.14 RATIONALE, AIMS AND OBJECTIVES FOR RESEARCH 
 
1.14.1 Rationale for Research 
This study aims to identify the profile of the patients treated for P. falciparum malaria and 
their clinical spectrum of disease at a university hospital in the heart of Gauteng, Helen 
Joseph Hospital (HJH). 
It is hoped that the data results obtained from the study would provide insight to the burden 
of malaria faced by a public tertiary institute. It would also serve to improve our 
understanding of the presentation and complications of P. falciparum malaria in a non 
endemic area of South Africa. 
1.14.2 Aims 
To assess the profile of patients with P. falciparum malaria at Helen Joseph Hospital between 
January 2009 and December 2010.  
1.14.3 Specific Objectives 
1. To describe patient demographics (age, sex, and travel history). 
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2. To describe clinical spectrum, laboratory findings and outcome of patients with P. 
falciparum malaria.  
3. Estimate the prevalence of HIV co-infection in those patients that are tested for HIV 
infection. 
4. To identify predictors of mortality in these patients admitted to ICU. 
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1. Site of Study 
The study was conducted at a tertiary academic institution, HJH, located in Gauteng. HJH 
provides healthcare to a large drainage area including mainly Randburg, Mayfair, Hilbrow 
and Florida. It is also a referral hospital for patients from two other secondary hospitals - 
Yusuf Dadoo and Leratong.  
 
2.2. Study Design and Sampling 
This is a retrospective study conducted on patients diagnosed with malaria at HJH over a 2 
year period between January 2009 and December 2010.  
The study sample consisted of 290 patients, both males and females over 14 years of age with 
smear and/or antigen positive for malaria. The diagnosis of malaria was confirmed with blood 
smears stained with Giemsa (thick and thin smears) and with the Rapid Antigen Test (RAT).  
A review was conducted of the malaria database processed at the National Health Laboratory 
Service (NHLS). All requested malaria tests including microscopy smear and RATs during 
the 2 year period were extracted. All results were printed with the patient name and hospital 
number. Those patients that were smear and/ or antigen positive results were included in the 
study. Patient files were subsequently retrieved from the records department in the hospital. 
Tests that were repeated on the same patient during that admission were not included. 
However, new separate admissions were included. The patient files which included an 
outpatient, casualty and inpatient notes were fully reviewed. Some files were unable to be 
traced possibly due to spelling errors of patient names and or incorrect hospital numbers. 
Outstanding blood results that were not found in the patients file were traced through the 
laboratory computer system at the hospital. 
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2.3. Data collection and diagnostic criteria for severe malaria 
Each patient was allocated a patient code. A standardized data sheet (Appendix A) was used. 
Information was obtained on: 
 Patient demographics: age; gender; place of citizenship; travel history and place.  
 Admission date. 
The clinical criteria were defined as per WHO criteria for falciparum malaria (WHO, 2000). 
Based on available clinical and laboratory parameters present during the admission, P. 
falciparum malaria was classified as complicated (severe) malaria or uncomplicated malaria. 
Severe falciparum malaria was diagnosed based on the presence of one or more criteria. HIV 
positivity and pregnant states are also considered high risk factors for complicated malaria 
and were therefore included as part of the criteria of severity.  
Clinical parameters assessed for severe malaria included the presence of: 
 Neurological features: this included firstly the presence of any impairment in the level 
of consciousness and secondly evidence of 2 or more seizures. 
 Pyrexia: temperature ≥ 40 o C.  
 Circulatory collapse: systolic blood pressure < 80mmHg or clinical features of 
hypovolaemic shock. 
 Respiratory distress: included dyspnoea; respiratory rate >32/min.  
 Pulmonary edema and ARDS (based on the assessment of the attending clinician). 
 Spontaneous bleeding: included epistaxis; haemoptysis; hematemesis; melena and 
macroscopic haematuria. 
 Splenomegaly: presence of a clinically palpable spleen was noted but this was not 
included in severity criteria. 
 Pregnancy; estimated gestational age. 
Laboratory parameters included:  
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 Bicarbonate level and blood pH; presence of acidosis if bicarbonate level < 15mmol/l 
and blood pH < 7.35. 
 Glucose level; presence of hypoglycemia if glucose < 2.2mmol/l. 
 Hemoglobin level; presence of severe anemia if Hb ≤ 5.0g/dl; a category of moderate 
anemia included Hb between 5.1 to 10g/dl. 
 Platelets level; presence of thrombocytopenia if platelets < 137 × 109/l. 
 Creatinine level; presence of severe renal failure if creatinine > 265µmol/l; a category 
of moderate renal failure included a creatinine level of 100 to 264.9 µmol/l. 
 Smear microscopy indicating Plasmodium species; level of parasitemia; 
hyperparasitemia indicated by a parasitemia level of ≥4%.  
 Rapid diagnostic antigen test 
 Bilirubin level; presence of jaundice if bilirubin > 50µmol/l 
 Lactate level; hyperlactatemia if lactate > 5mmol/l 
 HIV testing   
Final aspects that were assessed included:  
 Presence of severe malaria; number of criteria.  
 Management plan including inpatient or outpatient care; ICU admissions; treatment 
options; requirement of haemodialysis or mechanical ventilation. 
 Outcome: patient discharged or demised.  
Patient information was transferred from the data collection sheets onto an Excel spreadsheet.  
 
2.4. Ethics approval and other considerations 
Written permission to analyze patient files and blood results was granted by the CEO of the 
hospital. Consent was also granted by the NHLS based at the hospital.  
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The study was approved by the Postgraduate Committee, University of the Witwatersrand 
and the Committee for Research on Human Subjects (Appendix B) (medical) - Ethics 
approval number M110975.  
 
2.5. Statistical Analysis 
Data were entered into Microsoft Excel and Access which was then imported into Stata® 
(version 12.5, series 0414) for statistical analysis. Descriptive statistics were calculated. 
Description of categorical variables was illustrated with numbers and percentages and 
continuous variables with means and standard deviations (SD). Medians with inter-quartile 
range (IQR) were also used for variables with non parametric distribution. Associations 
between categorical values and patient outcomes were assessed with the Pearson’s chi square 
tests. The Students t- test was used for continuous variables and comparison of independent 
groups. A P value < 0.05 was considered as statistically significant.  
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CHAPTER 3 RESULTS 
 
In 2009 there were 87 patients reported to have had malaria and this increased to 203 cases in 
2010. Of the total 290 patients who tested positive for malaria by RATs or smear tests over 
the 2 years, 171 files (study population) were retrieved from the records department at the 
hospital.  
3.  
3.1. Demographic Information  
3.1.1. Age and Gender Distribution 
Figure 1 illustrates the age distribution of the study population. The median age was 28.5 
years (IQR 23-36). 
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Figure 1 Age distribution of the study group 
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The gender distribution as demonstrated in Figure 2 showed that males had a higher risk of 
malaria infection than females. Males accounted for 85% (146/171) of the confirmed cases 
compared to 15% (25/171) in females over the 2 year period.  
 
Figure 2 Gender distribution of the study population   
 
3.1.2. Travel history and Place of Citizenship  
3.1.2.1. Travel History 
Of the 171 patients reviewed, 164 (96%) had a positive travel history documented. Of these 
patients who travelled, the exact place of travel was noted in 97% (159/164) patients.  
However in the remaining 5 (3%) patients among those that had travelled, the travel place 
information was unobtainable either due to language barrier or the patient having a decreased 
level of consciousness and not being able to answer questions appropriately.  
The majority of malaria infections contracted was from outside South Africa (159/164 
[96%]). Locally acquired infections were 6/164 (4%) of which travel to Limpopo contributed 
3%. 
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The 4 main areas where malaria was acquired outside South Africa were Mozambique, 
Somalia, Zimbabwe, and Malawi. 
 
Figure 3 Percentage distribution of Travel Place 
 
3.1.2.2. Place of citizenship 
Approximately 55% (94/170) of the patients were non South African residents according to 
the demographic records charted in the file. The vast majority were Somali nationals 37/170 
(22%), followed by Mozambique nationals with 16/170 (9%), Malawi citizens 16/170 (9%) 
and Zimbabwe citizens 11/170 (6%).  
 
3.2. Seasonal Variation  
Although malaria cases were detected every month of the year, transmission was distinctly 
seasonal. There was a range of 17 to 28 malaria cases diagnosed each month between 
December to May (summer and autumn seasons) in both years. There were decreased malaria 
infections rates between June to November.   
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Figure 4 Seasonal Variation of patients with malaria 
 
3.3. Clinical Spectrum of Disease 
Table 1 presents the percentage distribution of patients diagnosed with malaria according to 
the clinical features. Pyrexia was the most common documented clinical feature found in 
43% of patients. Impaired consciousness was the second most predominant clinical feature, 
found in 12% of patients. Less so common was seizures in 2%.  
The presence of splenomegaly was sought for in 168 patients of whom 12% were found to 
have a clinically palpable spleen. This may be under estimated clinical finding as it is 
dependent on clinician clinical skill.  
Respiratory distress occurred with lesser frequency (6%), of which ARDS was diagnosed in 
50% of these patients.  
Circulatory collapse was evident in 5% patients.  
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Table 1: Clinical features of patients admitted with malaria at HJH 
  
Clinical features, n, % 
Yes 
Impaired Consciousness ( restlessness, 
disorientation, confusion, coma) 21 (12%) 
Seizures                                               
3 (2%) 
Pyrexia (Temperature ≥400C ) 
74 (43%) 
Circulatory Collapse (Systolic Blood Pressure 
< 70mmHg)          162 (94.74% 9 (5%) 
Respiratory Distress (tachypnoea, nasal 
flaring, dyspnoea) 10 (6%) 
Acute Respiratory Distress Syndrome (ARDS) 
5 (3%) 
Spontaneous Bleeding 
6 (4%) 
Splenomegaly (by palpation)*  
20 (12%) 
n = 171 except * n = 168  
 
3.4. Laboratory Features  
3.4.1. Hematological and biochemical tests 
Laboratory data is presented in Table 2. Thrombocytopenia was the most common laboratory 
finding, documented in almost 80% patients. In addition, anemia (Hb ≤ 10g/dl) was found in 
22%. The vast majority of patients with anemia (almost 90%)) were categorized into an 
intermediate group of moderate anemia (Hb 5.1 to 10). Severe anemia (Hb ≤ 5g/dl) was 
identified in 10% of anemia group (2% of total population).  
Renal failure according to WHO classification of severe malaria (creatinine > 265µmol/l), 
was present in almost 10%. However a quarter of the study population (26%) also had renal 
dysfunction with a creatinine values between 100 to 264.9µmol/l. 
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Acidosis was evident in 21% of the patients. Acidosis with associated renal failure was found 
in a third of these patients whilst two thirds were acidotic with no associated renal failure. 
Almost a third of the study population had biochemical jaundice. Hypoglycemia being 
increasingly recognized as a manifestation of severe malaria was found in only 2%.   
 
3.4.2. Malaria Tests 
Thick and thin smears were done on all 171 patients studied. Smear results revealed that 97% 
(165/171) had a positive smear for P. falciparum. Only one patient was found to have P. 
ovale. In 5 patients (3%) there were no parasites observed on smear microscopy.   
The RAT was positive in 170 patients (99%).  It was negative in the one patient found to 
have P. ovale.  
Hyperparasitemia was evident in 22%. Parasite densities ranged from < 1% to 39%. 
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Table 2: Laboratory findings of patients admitted with malaria at HJH 2009/2010 
 
Laboratory findings 
Yes 
Thrombocytopenia (Platelets < 137 x 10
9
/L) 
135/170 (79%) 
Anemia  
Hemoglobin > 10g/dl                                                        
Hemoglobin < 10g/dl                                                       
Hemoglobin 5.1-10g/dl (moderate anemia)                    
Hemoglobin < 5.0g/dl (severe anemia)                           
 
132/170 (78%) 
 
38/170 (22%) 
34/170 (20%) 
 
4/170 (2%) 
Acidosis (pH < 7.35 / Bicarbonate < 15 mmol/l) 
33/160 (21%) 
Renal Failure (Creatinine > 265 µmol/l)  
Creatinine < 100                                                                 
Creatinine 100 to 264.9                                                       
Creatinine > 265         
 
106/165 (62%) 
44/165 (26%) 
16/165 (10%) 
Jaundice (Serum Bilirubin > 43umol/l) 
37/134 (28%) 
Hypoglycemia (Glucose < 2.2 mmol/l)          3/146 (2.06%) 
3/146 (2.06%) 
Hyperlactatemia  (Lactate > 5 mmol/l) 
3/7 (43%) 
Rapid Antigen Test (RAT) 
170/171 (99%) 
Hyperparasitemia (Parasitemia ≥ 4%) 
38/170 (22%) 
Pregnant            
4/14 (29%) 
HIV reactive                     
27/49 (55%) 
 
3.5. Management  
 
3.5.1. Inpatient versus outpatient management 
A total of 11% (19/171) patients were managed as outpatients. Among the 152/171 (89%) 
inpatients, 12 patients (8%) required management in ICU.   
32 
 
3.5.2. Treatment options  
Of the 171 files assessed, seven patients were found to have either inadequate or no treatment 
for malaria due to lack of follow up of outpatient results. There were three patients that had 
absconded from the hospital.  
Among the remaining 161 patients, the most frequent treatment option was a combination of 
quinine and doxycycline given in 100 patients (62%). Quinine was used as monotherapy in 
38/161 (24%). The combination of quinine and clindamycin was used in 14/161 (9%). 
Coartem was the drug of choice in 8/161 (5%). Only one patient had received artesunate 
therapy.  
Data regarding loading dose of quinine was assessed in patients admitted to ICU. Of the 11 
patients for whom data was available, 8 were given an intravenous loading dose of quinine. 
There were no patients that had exchange transfusion.  
3.5.3. Outcome  
3.5.3.1. Mechanical Ventilation 
A total of 8 out of the 171 patients (5%) required mechanical ventilation.  
3.5.3.2. Haemodialysis 
There were 12 patients that required haemodialysis of which 11 had severe renal failure and 
one patient had moderate renal failure but had multiple other severe malaria criteria including 
ARDS.  
3.5.3.3. Discharge versus death  
Among the 152 inpatients, 137 (90%) were discharged from the hospital. There was 1 patient 
transferred to a down- referral hospital and 1 patient had refused further treatment. There 
were 3 patients that had absconded from the hospital.  
The mortality rate during the study period was 5.8% (10/171).  
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3.5.3.4. Malaria deaths  
There were 10 patients that demised during the study period due to malaria and its 
complications. All 10 patients had severe malaria fulfilling 3 or more criteria of severity. 
Females were found to have a higher mortality rate than males (12% and 5% respectively) 
however not statistically significant. There was one pregnant female that demised. There 
were no differences in age noted between those that demised and survivors.  
Clinical features that were strongly associated amongst these fatalities included impaired 
consciousness, respiratory distress and ARDS. Impaired consciousness was found in 7 of the 
patients. Respiratory distress occurred in 8 patients, of which 5 were found to have ARDS. 
Half of these patients had pyrexia. Three patients were found to have had seizures. There 
were nine patients with circulatory collapse and six with spontaneous bleeding.  
Laboratory tests in the demised group showed acidosis to be present in all 10 patients (p < 
0.005). Mean bicarbonate levels were as low as 12 mmol/l in the demised group (19 mmol/l 
in the survival group).  
Only one patient from the demised group had a creatinine level < 100 µmol/l. Severe renal 
failure was evident in 5 patients and moderate renal failure in 4. The mean creatinine was 
higher in the demised compared to the survivor group (309µmol/l and 112µmol/l 
respectively). Majority of the patients that demised had moderate anemia (70%). Only 1 
patient had severe anemia. The mean Hb was lower amongst the patients in the demised 
group (8g/dl) compared to survivors (12g/dl).  
All 10 patients had a hyper-parasitemia. The mean parasitemia among demised group was 
comparably higher at 23%. However the average amongst those discharged was 3%.  
Jaundice was found in 70% (7/10) of demised group and also with a higher level of bilirubin 
than survivors (average bilirubin was 173µmol/l and 43µmol/l respectively). Hyperlactatemia 
was found in 50% (5/10). Only 1 patient was found to have hypoglycemia.   
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Among the 10 patients that died, 7 were admitted in ICU and all 7 required mechanical 
ventilation. Haemodialysis was initiated in 5 patients. Data on quinine loading which was 
available for 6 of the 10 patients that demised showed that 4 had received the loading dose. 
Due to the small number of the demised group, many of the comparisons above were not 
found to be statistically significant.  
 
3.6. Gender differences and outcome  
The data analysis illustrated that females with falciparum malaria had a higher risk of severe 
malaria and its complications. There was one female that was infected with P ovale species.  
 
Table 3: Differences in gender and outcome  
 
 Females  Males  
Total malaria cases 25/171 (15%) 146/171 (85%) 
Severe malaria  19/25 (76%) 66/146 (45%)     p < 0.005 
≥3 Severe malaria criteria  11/19 (58%) 22/66 (33%) 
ICU admission  5/25 (20%) 7/146 (5%)          p < 0.05 
Impaired consciousness  6/25 (24%) 15/146 (10%)  
Hyper-parasitemia  11/24 (46%)  27/146 (19%)     p < 0.005 
Anemia  15/25 (60%)  23/145 (16%)     p < 0.0005 
Acidosis  9/22 (41%) 24/138 (17%)     p < 0.05 
Renal failure  5/24 (21%)  11/141 (8%)       p < 0.05 
Haemodialysis required  4/25 (16%)  8/141 (6%)  
Case fatalities   3/25 (12%) 7/141 (5%)  
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3.7. Malaria and pregnancy  
Among the 25 females of child bearing age, only 14 females were tested for pregnancy. Of 
the 14 females tested, 4 were found to be pregnant. Data on whether they were primigravidae 
was unavailable. All of them were in their first trimester. One pregnant female was found to 
have a glucose level of 2.5mmol/l, however this did not fulfill WHO criteria of hypoglycemia 
(glucose < 2.2mmol/l). Three of the four pregnant patients had moderate anemia but none 
fulfilling a diagnosis of severe anemia. The mean parasitemia among the pregnant women 
was higher than non-pregnant (10% and 5% respectively). Two of the four patients had 
severe malaria with 3 or more WHO criteria identified. There was one pregnant female who 
demised. She had fulfilled 4 severe malaria criteria. She was found to be HIV reactive and 
also required ventilation in ICU. 
 
3.8. Malaria and HIV  
Of the 49 patients tested for HIV, more than half (55%) tested positive. A comparison 
between the HIV reactive and non reactive group showed that impaired consciousness was 
doubled in the HIV group. Acidosis was more prevalent in the HIV positive group (40% and 
25% respectively) however statistically this was not significant. Anemia was also more 
common in the co-infected group (15/27 [56%] versus 6/22 [27%] in the HIV negative group 
[p < 0.005]). Among the HIV positive group, 27% (7/26) had severe renal failure comparing 
with 9% (2/22) of the negative group (statistically not significant). Hence a larger proportion 
of patients who were co-infected were dialyzed (22% versus 14%). Hyper-parasitemia 
however was higher among the HIV negative than positive patients (32% [7/22] versus 22% 
[6/27]).  
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Patients fulfilling ≥ 3 criteria was slightly higher in the HIV group (44%) compared to the 
negative group (38%). The death rate in the HIV positive and negative groups were similar 
(11% versus 9%).  
 
3.9. Complicated versus uncomplicated malaria 
The number of patients found with complicated and uncomplicated malaria was almost equal. 
There were 85/171 with complicated malaria and 86 with uncomplicated. There were no 
significant differences in age and gender among patients with complicated and uncomplicated 
malaria.  
 
3.10. ICU Admissions  
3.10.1. Clinical findings 
There were 12 patients admitted to the ICU. There were 7 males and 5 females (one 
pregnant). Of the twelve patients, eight had pyrexia. Six of the twelve patients had respiratory 
distress (p<0.005), with four of them complicating with ARDS. An impaired level of 
consciousness was more prevalent in ICU group (9/12) than non ICU patients (p<0.005). 
Less than two patients were found to have either circulatory collapse; seizures; abnormal 
bleeding or hypoglycemia. There were seven patients that had moderate anemia, however 
none were found to have severe anemia.  
The presence of acidosis was a strong risk factor for ICU admission. Acidosis was present in 
11 of the 12 patients (p<0.005).   
Among the 12 patients there were 9 patients that had renal failure and 6 of which were 
severe. Only 5 patients were tested for hyperlactatemia, 2 of which were high. 
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Hyperparasitemia was found in 11 of the 12 patients. The mean parasitemia density was 16%. 
All 12 patients were infected with P falciparum species. Almost 80% of these patients had 
jaundice. Only 7 patients were tested for HIV of which 5 were found to be positive.  
All 12 patients had severe malaria with a range of 4 to 10 criteria in each patient.  
With regard to administration of quinine loading dose the data for 1 patient was missing. 
However of the remaining 11 patients, 8 were given a loading dose of quinine.  
There were 8 patients that required mechanical ventilation and 7 patients that had been 
haemodialysed.  
Among the twelve patients admitted to ICU, seven demised (almost a 60% mortality rate).   
3.10.2. Predictors of mortality in ICU 
Table 4: Comparison of patients discharged and those that demised in ICU  
 
 
Discharged n, % Demised n, % 
Impaired LOC 5/5 (100) 4/7 (57) 
Seizures 1/5 (20) 1/7 (14) 
Pyrexia  4/5 (80) 4/7 (57) 
Circulatory collapse 0/5 2/7 (29) 
Respiratory distress 1/5 (20) 5/7 (71) 
ARDS  0/5 4/7 (57) 
Abnormal bleeding  1/7 (14) 1/7 (14) 
Acidosis  4/5 (80) 7/7 (100) 
Anemia  2/5 (40) 5/7 (71) 
Severe renal failure  2/5 (40) 3/7 (43) 
Hyperparasitemia  4/5  (80) 7/7 (100) 
Jaundice  5/5 (100) 4/6 (67) 
Hyperlactatemia  0/2 2/3 (67) 
HIV  2/2 (100) 3/5 (60) 
Quinine loading dose 4/5 (80) 4/6 (67) 
Haemodialysed 3/5 (60) 4/7 (57) 
Ventilated  1/5 (20) 7/7 (100) 
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Analysis of patients that demised and those that were discharged from ICU showed that age 
did not affect the outcome. The demised group had a higher risk of circulatory collapse. The 
mean systolic blood pressure was lower among the group that demised compared to ICU 
survivors (80mmHg and 99mmHg respectively). There was also a strong association of the 
demised patients having features of respiratory distress and ARDS. Further, all the patients 
from the demised group required mechanical ventilation.  
The demised group of patients had a higher risk of anemia, jaundice and acidosis. The mean 
creatinine was also found to be higher in the demised group (295µmol/l versus 250µmol/l). 
The mean parasitemia level was substantially higher in patients who demised than those 
discharged (25% and 7% respectively).   
The loading dose of quinine was given in 4/5 ICU survivor group and 4/7 ICU demised 
group.  
Due to the small numbers assessed in this group, the results were not found to be statistically 
significant except for the need for mechanical ventilation in the demised group (p < 0.005).   
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CHAPTER 4 DISCUSSION 
 
Summary of the Main Findings  
The escalation in the number of malaria cases reported at HJH from 2009 to 2010 showed a 
steep annual increase in the incidence of infection. Malaria notifications in the country have 
been shown to decrease substantially between 2000 and 2010 (Moonasar et al, 2011). This 
however may be controversial. A large study conducted in Gauteng province from 2005 to 
2006 illustrated that the malaria incidence was actually higher than what was reported to the 
DOH (Weber et al, 2010). This increase may be related to improved reporting (Weber et al, 
2010). More likely, it may probably be explained by the escalation of imported malaria and 
poor malaria chemoprophylaxis. Studies conducted in Soweto and Cape Town, showed 
significant numbers of imported malaria despite the area being non endemic (Cohen et al, 
2005. Opie et al, 2014).     
The median age of the study population was 28.5 years which were consistent with other 
studies done in SA (Opie et al, 2014. Ngomane et al, 2012. Weber et al, 2010). An alarming 
85% of patients were males compatible with the findings of other studies across our country 
(Opie et al, 2014. Ngomane et al, 2012). This is probably due to them searching for 
employment.  
A positive travel history was documented in 96% of the population. Interestingly, more than 
90% of malaria infections contracted was from neighboring countries outside South Africa. 
The 4 most popular areas of acquisition were Mozambique, Somalia, Zimbabwe, and Malawi. 
This was similar to a large study done across Gauteng’s public and private hospitals, where 
almost 83% of malaria was likely to be acquired from Mozambique (Weber et al, 2010). The 
study done on malaria at Chris Hani Baragwanath Academic Hospital (CHBAH) in Soweto 
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also showed the majority of infections were acquired from neighboring countries, mostly 
Mozambique (Perovic et al, 2000).    
More than half of the patients were non South African residents according to the 
demographic records charted in the file. Some patients were reported to be SA citizens on 
their demographic form, however it was found that there were language barriers and they 
spoke a foreign language. Hence this is probably an under estimated number of foreign 
residents. The vast majority of non South Africans were Somali nationals, followed by 
Mozambique, Malawi and Zimbabwe nationals. A study conducted in Cape Town found 
>90% of their study population to be foreign nationals, 48% being from Somalia (Opie et al, 
2014). One could extrapolate that given the dominant profile in our patients which encased a 
young male foreigner, employment is likely is driving force in this regard. It emphasizes the 
burden of imported malaria faced by the healthcare system both in Gauteng and South Africa 
as a whole. Gauteng, a non-endemic malaria area and the economic hub of the country, bears 
almost 20% of the country’s malaria burden specifically as imported malaria (Frean et al, 
2014).  
There was no history of any travel in 4% of the patients. They were diagnosed with malaria 
without having travelled outside Johannesburg. Neither was there any history of mechanical 
transmission like blood transfusion. This may have been cases of odyssean malaria. A study 
done in Gauteng identified a total number of forty six patients with odyssean malaria over an 
eight year period (Frean et al, 2014). Most of these patients were initially mis-diagnosed as 
influenza, viral hepatitis and septicemia. Malaria transmission rates were clearly seasonal 
with summer and autumn being the peak seasons. These peaks are probably related to both 
favorable climatic conditions and increased number of people travelling during these periods. 
January and February had the highest patient numbers and one may assume that this may 
have been related to more people travelling through endemic areas outside the country and 
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returning back after the festive period. Research studies have shown a correlation with people 
traveling to endemic areas to visit family having a higher risk of malaria than those traveling 
for ‘other’ reasons (Marks et al, 2014). This illustrates that intensive efforts from a 
prevention point is probably lacking.  
A delay in the diagnosis of malaria exponentially impacts disease severity and predicts 
outcome (Frean et al, 2014). The study conducted at the CHBAH revealed an average delay 
of 1 week in patients seeking help (Perovic et al, 2000). Further, there may be a low index of 
suspicion for the diagnosis of malaria infection in areas where malaria is non-endemic and 
not frequently seen. This may directly contribute to patient morbidity and mortality (Frean et 
al, 2014).     
Thrombocytopenia being the most common laboratory and hematological finding 
documented here has also been shown in other studies (Perovic et al, 2000). Malaria therefore 
remains an important differential diagnosis in a patient with thrombocytopenia irrespective of 
an existent travel history or not (Frean et al, 2014).    
An important cause of morbidity and mortality in patients with falciparum malaria is anemia. 
Of note the WHO guidelines emphasizes severe anemia with an Hb less than 5g/dl. This 
however was only illustrated in a menial 2% of the total amount of study group. The vast 
majority (20%) of patients were actually classified with moderate anemia. Further, repeated 
seizures and hypoglycemia although included in the study as part of the WHO guidelines was 
actually quite infrequently seen. This finding was also demonstrated in other studies outside 
Africa as well, thereby questioning the prognostic value of those specific criteria which may 
be more relevant in pediatric population (Bruneel et al, 2010. Sagaki et al, 2013).   
Almost 10% of patients had severe acute renal failure. This degree of renal failure was 
reflected in other studies done in South Africa (Opie et al, 2014). Again, a substantial number 
of patients (25%), although could not be classified as having severe renal failure according 
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WHO criteria, had moderate renal failure. The vast majority of patients with renal 
dysfunction improved with rehydration and anti-malarial therapy. There were 12 patients that 
required renal replacement therapy (RRT) and more than a third of them were in ICU. High 
levels of creatinine may be associated with increased mortality. Mortality in these patients 
may be as high as 75% without dialysis and reduced to 26% with it (Bruneel et al, 2003).  
Other studies done in South Africa have also found P. falciparum malaria to be the most 
common malaria parasite (Cohen et al, 2005. Perovic et al, 2000). Further, the symptoms 
caused by the other species like P. vivax, P. malariae and P. ovale are usually milder than 
that of P. falciparum (Cohen et al, 2005. Suh et al, 2004).  
Females had a higher risk of severe malaria and its complications (p < 0.005).  
Pregnant females are more susceptible to falciparum malaria than non pregnant females 
(McLean et al, 2015). Malaria infection in pregnant women and post partum period is well 
described. In this study pregnant females had twice the average parasitemia when compared 
to the non pregnant group. Higher parasite densities in pregnant women infected with the 
falciparum species has been documented (McLean et al, 2015). One of the four pregnant 
women in the study demised.  
Malaria and HIV has been reported to interact synergistically with each other (Pereira et al, 
2015). More than half of our patients tested for HIV were actually co-infected with malaria 
and HIV. This co-infection rate was found higher than the study done at the CHBAH where 
33% of patients were co-infected with HIV (Cohen et al, 2005). Patients from our cohort co-
infected with HIV had a higher risk of impaired consciousness, anemia, acidosis and renal 
failure. HIV positive patients had a slightly higher risk of severe malaria criteria. The 
mortality risk however was found to be similar in the positive and negative groups. The study 
done in Soweto illustrated that HIV positive patients had a tripled risk of severe malaria. 
There was an increased prevalence of severe malaria in patients with CD4 counts less than 
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200 x 10
6
 cells/l. Secondly they also showed that HIV positive patients had a higher risk of 
anemia, acidosis and renal failure (Cohen et al, 2005). Unfortunately patients co-infected 
have been shown to have a greater delay in malaria diagnosis compared to that of HIV 
negative patients (Cohen et al, 2005). The management of a co-infected patient requires 
vigilance, close monitoring and a low threshold for escalation into a high-care or ICU. 
Similar to other studies outside Africa, there were no significant differences in age among 
patients with complicated and uncomplicated malaria (Sagaki et al, 2013). The study done in 
Thailand found that the presence of clinical jaundice with any other vital organ dysfunction 
was the most common complication noted (Sagaki et al, 2013).  
Patients with severe falciparum malaria should be managed in a high care or ICU. In studies 
conducted outside Africa, patients with both severe and less severe malaria were admitted 
into ICU (Bruneel et al, 2003). Due to limited resources in our country however, this is 
unfortunately not feasible. Even patients with severe falciparum malaria may sadly not reach 
ICU due to resource constraints and will remain in a general medical ward. ICU bed 
availability was the predominant determining factor for ICU admission. Consequently, only 
14% of patients with severe malaria had the benefit of ICU care. There were certain 
parameters that one could associate as predictors for requiring more intensive care and 
monitoring. These included the presence of impaired level of consciousness, respiratory 
distress, ARDS, moderate anemia, acidosis, renal failure, jaundice and hyper-parasitemia 
(p<0.005). All 12 patients that were admitted to ICU had a minimum of 4 criteria. A previous 
study outside Africa showed that patients with severe falciparum malaria having ≥ 3 criteria 
had almost an 80% sensitivity and specificity for requiring ICU admission (Sagaki et al, 
2013). 
In our study admission into ICU inadvertently escalated ones mortality risk due to their 
critical state at that point. We found four predictors of mortality in the ICU category of 
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patients. These included severe hypotension, respiratory distress and/or ARDS and lastly 
those patients requiring mechanical ventilation. The presence of shock, acidosis, coma and 
pulmonary edema were the main associated features with mortality that was found in the 
study in France (Bruneel et al, 2003).  
The patients that were admitted to ICU were in a profoundly critical state. Consequently and 
naturally their risk of mortality as expected accelerated.     
The vast majority of patients (85%) were treated with quinine either as monotherapy or in 
combination with another agent. A quarter of the patients were treated inadequately with 
quinine as monotherapy. The loading dose of quinine failed to change the outcome in the 
demised group when compared to survivors.  
Only 5% of patients were treated with coartem despite its convenient dosing and better side 
effect profile. This may have been related to drug availability.  
The availability of artesunate has been restricted in numerous countries including the UK and 
South Africa (Marks et al, 2014). During the study period only one patient was treated with 
intravenous artesunate. The reason for this is likely that artesunate was only approved for use 
by the Medicines Control Council (MCC) in June 2009. Further, due to the nature of the 
approval process, informed consent was necessary. This may have posed a potential 
challenge bearing in mind that the majority of patients were foreign nationals in the study and 
were unable to comprehend or communicate in English.   
Amongst the ten patients that succumbed to death a minimum of 3 or more criteria of severity 
were present. The clinical features that were strongly associated with these fatalities were 
impaired consciousness, respiratory distress, and ARDS. Laboratory complications associated 
with death included metabolic acidosis, renal failure, hyper-lactatemia and jaundice. Despite 
the technician based variability identified with parasite counts across different institutes, 
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hyperparasitemia was undoubtedly elevated in every single patient that succumbed to death 
from malaria.  
Severe imported malaria even in the hands of the highly skilled and expert institute 
nonetheless carries a significant mortality rate (Bruneel et al, 2010). The case fatality rate in 
returning travelers with severe falciparum malaria may exceed 20%, despite being managed 
in an ICU (Trampuz et al, 2003). The case fatality rate during the study period was 5.8%. 
This is however higher than the national target of 0.5%. It may be attributed to the fact that 
the study was conducted at a tertiary and referral institute and hence the burden of 
complicated malaria was higher. Time to presentation to health care facility may have played 
a role too. Studies have demonstrated that referral centers were more likely to see severe 
complicated malaria secondary to delayed diagnosis and ineffective therapy (Sagaki et al, 
2013). A study done outside South Africa evidently found that if the first presentation was to 
a general practitioner rather than a hospital, the risks of severe malaria escalated immediately 
by 40% (Seringe et al, 2011).  Finally, it must also be emphasized that not all patients with 
severe complicated malaria that are deserving of ICU management, actually succeed to 
getting to ICU. Living in a country with resource constraints and managing these critically ill 
patients in a general ward creates a battle against the odds of survival.  
 
LIMITATIONS  
 
Due to it being a retrospective study, retrieving patient files from records department actually 
was a difficult task. One has to rely on the doctor’s interpretation and diagnostic skills. 
Definitions become difficult to apply. Further, accurate interpretation of handwriting was 
sometimes a problem to decipher. 
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CONCLUSION    
     
A striking correlation exists between malaria and poor socio-economic areas. Malaria carries 
with it a huge burden both globally and locally. Unprecedented achievement has been 
attained in malaria control globally and also in our country. Imported malaria however 
remains a huge challenge especially in non endemic industrialized regions like Gauteng. The 
escalation of immigrant workers travelling through endemic regions into Gauteng in the face 
of employment has been a critical point (Weber et al, 2010). South Africa was the main 
overall destination country of thousands of new asylum seekers between 2006 and 2011 
(Opie et al, 2014). Presentation to a health institute frequently follows recent travel of foreign 
migrants. This places an undue pressure on the financial burden of the health system of the 
country. Imported malaria contributed to an over-whelming 96% of the population studied. 
The predominance of young male foreigners probably reflects desperate individuals likely in 
search of employment or even a place of refuge. The crucial point is the fact that many of 
these patients have failed to take the appropriate chemoprophylaxis (Bruneel et al, 2003). 
Despite these patients travelling so frequently to endemic areas and back, there is a lack of 
insight on malaria and its complications. Malaria is preventable and curable. There should 
certainly be room for improvement from a prevention point. This may entail pre-travel 
assessments and education (Suh et al, 2004). The non specific nature of the disease can result 
in diversion of clinicians from the diagnosis. A diagnosis of malaria must be entertained as a 
differential diagnosis in any patient with imported fever (Marks et al, 2014). A negative 
travel history however should never negate the possibility of the diagnosis. The entity of 
odyssean malaria should be considered.  
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The ultimate goal is aimed at a reduction in morbidity and mortality. Failure to recognize and 
initiate prompt treatment directly impacts on morbidity and mortality (Trampuz et al, 2003. 
Perovic et al, 2000).   
According to a previous study, patients with severe malaria who meet ≥ 5 WHO criteria may 
have a mortality rate of 50% (Sagaki et al, 2013). Not all the WHO criteria may be relevant 
when assessing an adult patient with imported malaria (Bruneel et al, 2003). The 
identification of clinical predictors of severity for falciparum malaria through various studies 
across the world has illustrated much disparity (Sagaki et al, 2013). Major complications 
associated with severe malaria can develop rapidly. Once again, this highlights that early 
diagnosis and institution of appropriate therapy may well improve patient outcome (Sagaki et 
al, 2013). The critical care management in patients with severe malaria is an important aspect 
demanding meticulous and multi-disciplinary care (Marks et al, 2014). Understanding the 
concepts of fluid balance and requirements for mechanical ventilation and hemo-dialysis 
should be well known to the attending clinician. Over the decades the mortality rate 
associated with malaria has clearly delineated the strengths and weakness that exists between 
the health care system and the patient (Mehta et al, 2007).   
 The importance of exercising pharmaco-vigilance cannot be over-emphasized.  
Screening for HIV and malaria co-infection is crucial. The interaction between malaria and 
HIV infections can constitute a challenge. The association between low CD4 T cell counts 
and severe malaria is well described (Cohen et al, 2005). Further, progression of HIV 
infection to Acquired Immune Deficiency Syndrome (AIDS) can occur with co-infected 
patients (Pereira et al, 2015). All patients returning from malaria endemic area should be 
screened for malaria and HIV (Pereira et al, 2015). 
Considerable progress has been made in malaria prevention and management however there 
are still significant gaps that exist specifically in resources. More emphasis on resource 
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allocation is fundamental in the strategy of prevention, control and treatment. Exceptional 
surveillance measures are vital for swift detection and therapy. We need to be collaborating 
with health care workers across all levels to strengthen our health system. Every effort should 
be made to pursue streamlined training for health care providers, starting at a community 
level and filtering up to tertiary hospitals and Intensive Care Units. There should be improved 
awareness and education. The magnitude of the burden of imported malaria both locally and 
abroad is a crucial problem at hand. There should be more focus on intensifying regional 
cross borders movements with the vision of reducing imported malaria infection. One needs 
to embrace solutions that emulate the actual mobility of population presently. Going forward, 
research specifically in non endemic countries is lacking. There should be proposed research 
studies aimed and focusing on anti-malarial drug resistance, new anti-malarial agents and 
malaria vaccines. Medicine is always evolving and improved data on all these factors will be 
a platform for addressing gaps and solutions thereof.    
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APPENDIX 2 
Data Collection Form:  
Malaria - Profile of Patients and Complications at Helen Joseph 
Hospital 
Patient Demographics: 
1. Patient code ….… 
2. Age:   ……years 
3. Sex:   Male……   Female…… 
Travel history (last 12 months) 
Yes   ……..Where (……………..)     No…….. 
Place of Residence: …………………  
Admission month: 
Clinical: 
1. Impaired Consciousness:   Yes …….    No…….. 
2. Seizures:   Yes ……     No   ……. 
3. Pyrexia:   Yes ……  No ……. 
4. Circulatory collapse:   Yes   …..   No ……Systolic BP ……... 
5. Respiratory distress:   Yes   ……   No …… 
6. Pulmonary edema:    Yes   …..   No …… 
7. Abnormal bleeding:    Yes   ……   No…… 
8. Pregnant:   Yes …… (Gestation   ….)       No…… 
9. Splenomegaly:  Yes ……No……     
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Laboratory 
 
 
 
VCT offered:  Yes …..(Positive….    Negative …..)   Not tested ….. 
Severe Malaria:   Yes …….    (Number of criteria …….)      No   …… 
 
 
 
Management Plan: 
Outpatient   …….      Ward patient ……….       ICU    ……… 
Treatment: 
1. Co-artem    ………. 
Indicators Normal Values Criteria Yes 
(Actual 
Values) 
No 
(Actual 
Values) 
Not 
found 
      
Acidosis 7.33 – 7.44 PH < 7.35    
 18 – 29mmol/L Bicarbonate < 
15 
   
      
Hypoglycemia 4.2 – 7.1 Glucose < 2.2    
      
Severe Anemia 14.3 – 18.3g/dl HB < 5.0    
      
Thrombocytopenia 137 – 373x109/l Platelets < 137    
      
Renal Failure Creatinine 64- 104 
ml/min/1.73m2 
Creatinine > 265    
Plasmodium species      
Parasitemia N/A < 4%    
      
  >/= 4%    
      
Rapid Diagnostic  
Antigen Test  
N/A N/A    
      
Jaundice 0 – 21 umol/l Total bilirubin > 
50 
   
      
 Lactate 0.5 2.2 mmol/l Lactate > 5     
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2. Quinine    ……….. 
3. Quinine + Doxycycline    ………. 
4. Quinine + Clindamycin   ……….. 
5. Artesunate   ………… 
Outcome:  Discharged ………    Demised   ……….. 
 
 
 
